Description
MOTS-c (mitochondrial open reading frame of the 12S rRNA-c) is a novel 16-amino acid peptide encoded by the mitochondrial genome that plays a crucial role in metabolic regulation and cellular homeostasis. Its primary mechanism of action involves the activation of the AMP-activated protein kinase (AMPK) pathway, a master regulator of cellular energy metabolism. By activating AMPK, MOTS-c enhances glucose uptake and utilization in skeletal muscle, improves insulin sensitivity, and promotes fatty acid oxidation.
Key research areas for MOTS-c include its potential therapeutic applications in metabolic disorders such as type 2 diabetes, obesity, and non-alcoholic fatty liver disease. Studies have also demonstrated its role in regulating bone metabolism, preventing muscle atrophy, and modulating inflammatory responses. As a mitochondrial-derived peptide, MOTS-c is at the forefront of research into mitochondria-to-nucleus signaling and its impact on aging and age-related diseases.
This product is intended for research purposes only and is not for human consumption.
CAS: 1627580-64-6
PubChem CID: 146675088
Molecular Formula: C101H152N28O22S2
Molecular Weight: 2174.62 g/mol
Amino Acid Sequence: Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg (16 aa)
Physical Form: Lyophilized Powder
Purity: ≥99%
Storage: -20°C, protected from light and moisture


